Selective phosphodiesterase 9A inhibitors as medicaments for improving cognitive processes

US7737156B2 · kind B2 · utility

Assignee

• Boehringer Ingelheim International GmbH · DE

Inventors

• Frank-Gerhard Böβ · Grafton, GB
• Christina Erb · Wiesbaden, DE
• Martin Hendrix · Tarrytown, US
• Marja Van Kampen · Neu-Isenburg, DE
• Frank Wunder · Wuppertal, DE

Key dates

• Filing date: Aug 11, 2003
• Grant date: Jun 15, 2010
• Expiry date: Jun 23, 2026

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D473/30
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to the use of selective phosphodiesterase 9A (PDE9A) inhibitors for producing medicaments for improving perception, concentration, cognitive processes, learning and/or memory.